Search
for
Sort by
Research 961–990 of 1000+
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Disturbed Keratinocyte Differentiation in Transgenic Mice and Organotypic Keratinocyte Cultures as a Result of Spermidine/Spermine N1-Acetyltransferase Overexpression
- Association of Lifelong Intake of Barley Diet with Healthy Aging: Changes in Physical and Cognitive Functions and Intestinal Microbiome in Senescence-Accelerated Mouse-Prone 8 (SAMP8)
- Hodgkin′s lymphoma presenting as alopecia
- Overexpression of hypoxia-inducible factor-1α in hidradenitis suppurativa: the link between deviated immunity and metabolism
- Zinc and Zinc Transporters in Dermatology
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
- Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy
- Standard operating protocol for utilizing energy‐based devices in aesthetic practice
- Analysis of Isotretinoin-Induced Alterations in the Levels of Plasma Trace Elements: Investigation of the Relationship Between Magnesium, Phosphorus, Potassium, Zinc, and Treatment-Related Side Effects
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Extra-Intestinal Manifestation of Celiac Disease in Children
- Barley disease susceptibility factor RACB acts in epidermal cell polarity and positioning of the nucleus
- Mesotherapy: What is new?
- Scientific opinion on the tolerable upper intake level for selenium
- Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- Dermatoses of Pregnancy
- Comparative Study of a Topical and Oral Combination Therapy Containing Oleanolic Acid, Apigenin, and Biotinyl Tripeptide-1 in Patients with Androgenetic Alopecia: A Prospective, Open-Label Trial
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- Dietary Influences on Skin Health in Common Dermatological Disorders
- Efficacy of autologous platelet‐rich plasma combined with a non‐cross‐linked hyaluronic acid compound in the treatment of female androgenetic alopecia: A retrospective, case‐series study
- Enteropathica Acrodermatitis Complicated by Necrotising Fasciitis in an Infant Admitted to the Paediatric Emergency Department of the Gabriel Touré University Hospital
- Alopecia em pacientes anticoagulados
- Guidelines based management of androgenetic alopecia
- Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study